Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
Alectinib vs Crizotinib in ALK+ NSCLC: Final ALEX Data
2 weeks ago
reachmd.com
ALK Inhibitors for ALK NSCLC
ALK Inhibitors for ALK NSCLC
23 views7 months ago
vumedi.com
Emerging ALK/ROS1 TKIs for NSCLC | OncLive
Emerging ALK/ROS1 TKIs for NSCLC | OncLive
Jan 31, 2017
onclive.com
Patterns of Progression on Crizotinib for ALK NSCLC | OncLive
Patterns of Progression on Crizotinib for ALK NSCLC | OncLive
Apr 27, 2017
onclive.com
WCLC 2025 Insights: ALK-Rearranged NSCLC - Targeted Therapies in Early Stage Disease
WCLC 2025 Insights: ALK-Rearranged NSCLC - Targeted The…
6 months ago
vumedi.com
Dr. Drilon on Treatment Selection Considerations in ALK NSCLC | OncLive
Dr. Drilon on Treatment Selection Considerations in ALK NSCLC | O…
Dec 12, 2019
onclive.com
Optimal Management of Stage IV ALK-Rearranged NSCLC
Optimal Management of Stage IV ALK-Rearranged NSCLC
62 viewsMar 20, 2025
vumedi.com
Treating Newly Diagnosed ALK NSCLC | OncLive
Jan 14, 2019
onclive.com
ALK Inhibitor Sequencing in NSCLC | OncLive
Jan 31, 2017
onclive.com
ALK-Positive NSCLC: ASCEND-4 Trial | OncLive
Jul 12, 2019
onclive.com
Managing ALK-Positive NSCLC Disease Progression | OncLive
Feb 4, 2020
onclive.com
Utilizing Next-Generation ALK Inhibitors in NSCLC | OncLive
Jul 16, 2014
onclive.com
Priority Review in Ovarian Cancer, Rolling Submission in ALK-Positiv…
Sep 2, 2016
onclive.com
Available Therapies for ALK-Rearranged NSCLC | OncLive
Feb 26, 2019
onclive.com
Considerations for Sequencing in ALK NSCLC | OncLive
Jun 16, 2017
onclive.com
Treating ALK-Mutated NSCLC With Disease Progression | OncLive
Jul 26, 2018
onclive.com
Development of ALK-Targeted Therapy for NSCLC | OncLive
Jun 16, 2017
onclive.com
Testing for ALK Rearrangements in Advanced NSCLC | OncLive
Feb 19, 2025
onclive.com
Dr. Huang on Research in ALK NSCLC | OncLive
Apr 26, 2022
onclive.com
Evolving Approaches for Treating ALK-Positive NSCLC | OncLive
Jun 23, 2017
onclive.com
Next Steps: Post-Frontline Therapies and Resistance in ALK …
10 months ago
ajmc.com
Second-Line Treatment for ALK-Positive NSCLC | OncLive
Jul 12, 2019
onclive.com
Dr. Konduri on Sequencing Challenges in ALK NSCLC | OncLive
Sep 8, 2020
onclive.com
Upfront Therapy for ALK/ROS1-Rearranged NSCLC | OncLive
Oct 17, 2017
onclive.com
2:49
Dr Nieva on the Rationale for Comparing ALK Inhibitors in ALK …
9 months ago
onclive.com
ALTA II: Brigatinib in Crizotinib-Resistant ALK NSCLC | OncLive
Jul 12, 2019
onclive.com
Dr. Villaflor Discusses Alectinib in ALK NSCLC | OncLive
Oct 5, 2017
onclive.com
Dr. Liu on Navigating the Frontline Treatment of ALK NSCLC | OncLive
Nov 9, 2018
onclive.com
Dr. Aggarwal on Emerging Treatment Approaches in ALK NS…
Jul 23, 2020
onclive.com
Upfront Use of Second-Line Agents in ALK NSCLC | OncLive
Apr 27, 2017
onclive.com
See more videos
Static thumbnail place holder